All In Biotech

Drug Trial Radar · NCT00526318

Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma

Trial Protocol for the Treatment of Children With High Risk Neuroblastoma (NB2004-HR)

Last checked: Nov 20, 2026Latest source record: Jul 16, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 360 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

360

Planned (sponsor's estimate)

Start

Jan 2007

Primary completion

Dec 2016

Sponsor

Sponsor type
Academic, hospital or other
First posted
Sep 10, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Primary purpose
Treatment
Who can join
All sexes, up to 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Giving chemotherapy before an autologous stem cell transplant stops the growth of tumor cells by stopping them from dividing or by killing them. It also prepares the patient's bone marrow for the stem cell transplant. The stem cells are given to the patient to replace the blood-forming cells that were destroyed by the chemotherapy. Giving isotretinoin after transplant may kill any remaining tumor cells. It is not yet known which combination chemotherapy regimen is more effective when given before a stem cell transplant and isotretinoin in treating neuroblastoma. PURPOSE: This randomized clinical trial is studying two different combination chemotherapy regimens to compare how well they work when given before a stem cell transplant and isotretinoin in treating young patients with high-risk neuroblastoma.

Conditions

  • Neuroblastoma

Interventions

  • filgrastimBiological

  • carboplatinDrug

  • cisplatinDrug

  • cyclophosphamideDrug

  • dacarbazineDrug

  • doxorubicin hydrochlorideDrug

  • etoposide phosphateDrug

  • ifosfamideDrug

  • isotretinoinDrug

  • melphalanDrug

  • topotecan hydrochlorideDrug

  • vincristine sulfateDrug

  • vindesineDrug

  • autologous hematopoietic stem cell transplantationProcedure

  • iobenguane I 131Radiation

  • radiation therapyRadiation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Event-free survival (EFS)

Locations

68 sites in 2 countries. Site status is shown where the registry gives one.

  • Kinderklinik - Universitaetsklinikum Aachen

    Aachen, Germany · Recruiting

  • Klinikum Augsburg

    Augsburg, Germany · Recruiting

  • Klinikum Bayreuth

    Bayreuth, Germany · Recruiting

  • Helios Klinikum Berlin

    Berlin, Germany · Recruiting

  • Charite University Hospital - Campus Virchow Klinikum

    Berlin, Germany · Recruiting

  • Evangelisches Krankenhauus Bielfeld

    Biefeld, Germany · Recruiting

  • Kinderklinik der Universitaet Bonn

    Bonn, Germany · Recruiting

  • Staedtisches Klinikum - Howedestrase

    Braunschweig, Germany · Recruiting

  • Klinikum Bremen-Mitte

    Bremen, Germany · Recruiting

  • Klinikum Chemnitz gGmbH

    Chemnitz, Germany · Recruiting

  • Klinikum Coburg

    Coburg, Germany · Recruiting

  • Children's Hospital

    Cologne, Germany · Recruiting

  • Carl - Thiem - Klinkum Cottbus

    Cottbus, Germany · Recruiting

  • Vestische Kinderklinik

    Datteln, Germany · Recruiting

  • Klinikum Lippe - Detmold

    Detmold, Germany · Recruiting

  • Klinikum Dortmund

    Dortmund, Germany · Recruiting

  • Universitatsklinikum Carl Gustav Carus

    Dresden, Germany · Recruiting

  • Klinikum Duisburg

    Duisburg, Germany · Recruiting

  • Universitaetsklinikum Duesseldorf

    Düsseldorf, Germany · Recruiting

  • Helios Klinikum Erfurt

    Erfurt, Germany · Recruiting

  • Universitaets - Kinderklinik

    Erlangen, Germany · Recruiting

  • Universitaetsklinikum Essen

    Essen, Germany · Recruiting

  • Klinikum der J.W. Goethe Universitaet

    Frankfurt, Germany · Recruiting

  • Universitaetskinderklinik - Universitaetsklinikum Freiburg

    Freiburg im Breisgau, Germany · Recruiting

  • Kinderklinik

    Giessen, Germany · Recruiting

  • Universitaetsklinikum Goettingen

    Göttingen, Germany · Recruiting

  • Universitats - Kinderklinik

    Greiswald, Germany · Recruiting

  • Universitaetsklinikum Halle

    Halle, Germany · Recruiting

  • Krankenhaus St. Elisabeth und St. Barbara

    Halle, Germany · Recruiting

  • University Medical Center Hamburg - Eppendorf

    Hamburg, Germany · Recruiting

  • Medizinische Hochschule Hannover

    Hanover, Germany · Recruiting

  • Universitaets-Kinderklinik Heidelberg

    Heidelberg, Germany · Recruiting

  • Gemeinschaftskrankenhaus

    Herdecke, Germany · Recruiting

  • Universitaetsklinikum des Saarlandes

    Homburg, Germany · Recruiting

  • Universitaets - Kinderklinik

    Jena, Germany · Recruiting

  • Staedtisches Klinikum Karlsruhe gGmbH

    Karlsruhe, Germany · Recruiting

  • Klinikum Kassel

    Kassel, Germany · Recruiting

  • University Hospital Schleswig-Holstein - Kiel Campus

    Kiel, Germany · Recruiting

  • Klinikum Kemperhof Koblenz

    Koblenz, Germany · Recruiting

  • Klinikum Krefeld GmbH

    Krefeld, Germany · Recruiting

Showing 40 of 68 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.